RIMANTADINE HYDROCHLORIDE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Rimantadine Hydrochloride, and when can generic versions of Rimantadine Hydrochloride launch?
Rimantadine Hydrochloride is a drug marketed by Chartwell Rx, Impax Labs, and Impax Labs Inc. and is included in three NDAs.
The generic ingredient in RIMANTADINE HYDROCHLORIDE is rimantadine hydrochloride. There are three drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the rimantadine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Rimantadine Hydrochloride
A generic version of RIMANTADINE HYDROCHLORIDE was approved as rimantadine hydrochloride by IMPAX LABS on August 30th, 2002.
Summary for RIMANTADINE HYDROCHLORIDE
| US Patents: | 0 |
| Applicants: | 3 |
| NDAs: | 3 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 149 |
| Clinical Trials: | 6 |
| Patent Applications: | 1,454 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | RIMANTADINE HYDROCHLORIDE at DailyMed |
Recent Clinical Trials for RIMANTADINE HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| University of Oxford | Phase 2/Phase 3 |
| Cancer Research UK | |
| The Leeds Teaching Hospitals NHS Trust |
Pharmacology for RIMANTADINE HYDROCHLORIDE
| Drug Class | Influenza A M2 Protein Inhibitor |
| Mechanism of Action | M2 Protein Inhibitors |
Medical Subject Heading (MeSH) Categories for RIMANTADINE HYDROCHLORIDE
Anatomical Therapeutic Chemical (ATC) Classes for RIMANTADINE HYDROCHLORIDE
US Patents and Regulatory Information for RIMANTADINE HYDROCHLORIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chartwell Rx | RIMANTADINE HYDROCHLORIDE | rimantadine hydrochloride | TABLET;ORAL | 076375-001 | Jan 14, 2003 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Impax Labs | RIMANTADINE HYDROCHLORIDE | rimantadine hydrochloride | TABLET;ORAL | 076132-001 | Aug 30, 2002 | RX | No | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Impax Labs Inc | RIMANTADINE HYDROCHLORIDE | rimantadine hydrochloride | TABLET;ORAL | 075916-001 | Nov 2, 2001 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
